Boehringer Ingelheim India and Lupin expand collaboration
MediaInfoline
Jul 12
Boehringer Ingelheim and Lupin Limited (Lupin) today announced the expansion of their partnership with plans to market two new oral anti-diabetics recently approved by the Drugs Controller General of India (DCGI) – Gibtulio Met®(Empagliflozin + ...
